Jaka jest cena za Lexaria Bioscience Corp. (LEXXW)

Cena za Lexaria Bioscience Corp. (LEXXW) wynosi $0.0012

Jaka jest kapitalizacja rynkowa dla Lexaria Bioscience Corp. (LEXXW)

Kapitalizacja rynkowa dla Lexaria Bioscience Corp. (LEXXW) wynosi $29.83K

Lexaria Bioscience Corp. (LEXXW) Historia Cen

Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

Rok	Wydajność
2026 (TTM)	152.82%
2025	-97.34%
2024	67.56%
2023	-1.68%
2022	-72.86%
2021	0.00%

Rok

Wydajność

2026 (TTM)

152.82%

2025

-97.34%

2024

67.56%

2023

-1.68%

2022

-72.86%

2021

0.00%

Firma	Cena akcji	Zmiana 1r%	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	$527.87	33.33%	US
Argenx SE ARGX.US	$873.57	35.10%	NL
Lonza Group AG LONN.SW	$742.88	8.64%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$261.43	17.34%	BE

Firma

Cena akcji

Zmiana 1r%

Kraj